Stock listing
Cns Pharmaceuticals, Inc.
Selected listing: BE50 · FWB · EUR · DE
Cns Pharmaceuticals, Inc. (Frankfurt:BE50), Health Technology. Latest release Sep 1, 2026: CNS Pharmaceuticals Details Business Development Strategy Driving…
- Ticker
- Frankfurt:BE50
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Cns Pharmaceuticals, Inc.
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
September 1, 2026
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
August 27, 2026
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
August 12, 2026
CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Oversubscribed $22.5M Financing, Growth Strategy in Investor Presentation
June 8, 2026
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
June 8, 2026
Research Cns Pharmaceuticals, Inc.
Cns Pharmaceuticals, Inc. company profile
View the public company page for Cns Pharmaceuticals, Inc. on 6ix.
Cns Pharmaceuticals, Inc. news
Read company news and market updates connected to Cns Pharmaceuticals, Inc..
Cns Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Cns Pharmaceuticals, Inc..